NewAmsterdam Pharma (NAMSW) Short Interest Ratio & Short Volume $13.59 +0.22 (+1.65%) (As of 11/14/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestTrends NewAmsterdam Pharma Short Interest DataNewAmsterdam Pharma (NAMSW) has a short interest of 5,000 shares. This marks a -16.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 9,904 shares to cover all short positions.Current Short Interest5,000 sharesPrevious Short Interest6,000 sharesChange Vs. Previous Month-16.67%Dollar Volume Sold Short$43,500.00Short Interest Ratio1.2 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume4,879 sharesAverage Trading Volume9,904 sharesToday's Volume Vs. Average49% Short Selling NewAmsterdam Pharma? Sign up to receive the latest short interest report for NewAmsterdam Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNAMSW Short Interest Over TimeNAMSW Days to Cover Over TimeNAMSW Percentage of Float Shorted Over Time Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. NewAmsterdam Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20245,000 shares $43,500.00 -16.7%N/A1.2 $8.70 10/15/20246,000 shares $51,000.00 -52.8%N/A1.9 $8.50 9/30/202412,700 shares $88,900.00 +58.8%N/A3.7 $7.00 9/15/20248,000 shares $53,680.00 -3.6%N/A2.2 $6.71 8/31/20248,300 shares $56,772.00 +33.9%N/A1.9 $6.84 8/15/20246,200 shares $47,368.00 +1,966.7%N/A1.4 $7.64 Get the Latest News and Ratings for NAMSW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024300 shares $1,950.00 -97.6%N/A0.1 $6.50 7/15/202412,500 shares $118,125.00 -33.9%N/A3.9 $9.45 6/30/202418,900 shares $164,808.00 +56.2%N/A6.1 $8.72 6/15/202412,100 shares $108,900.00 +21.0%N/A2.2 $9.00 5/31/202410,000 shares $78,999.00 +25.0%N/A1.4 $7.90 5/15/20248,000 shares $72,000.00 -11.1%N/A0.8 $9.00 4/30/20249,000 shares $94,500.00 -32.3%N/A0.9 $10.50 4/15/202413,300 shares $139,650.00 +66.3%N/A1.1 $10.50 3/31/20248,000 shares $88,320.00 -30.4%N/A0.4 $11.04 3/15/202411,500 shares $120,865.00 -13.5%N/A0.7 $10.51 2/29/202413,300 shares $143,507.00 +79.7%N/A1 $10.79 2/15/20247,400 shares $65,934.00 -31.5%N/A0.6 $8.91 1/31/202410,800 shares $100,980.00 -70.7%N/A1 $9.35 1/15/202436,800 shares $227,424.00 +0.6%N/A3.3 $6.18 12/31/202336,600 shares $114,558.00 +5.2%N/A6.8 $3.13 12/15/202334,800 shares $85,608.00 -1.1%N/A6.3 $2.46 11/30/202335,200 shares $82,368.00 +13.6%N/A4.2 $2.34 11/15/202331,000 shares $68,200.00 -37.5%N/A3.3 $2.20 10/31/202349,600 shares $86,800.00 +12.7%N/A4.7 $1.75 10/15/202344,000 shares $61,600.00 +53.9%N/A4.3 $1.40 9/30/202328,600 shares $54,340.00 +23.3%N/A1.8 $1.90 9/15/202323,200 shares $43,848.00 +91.7%N/A1.5 $1.89 8/31/202312,100 shares $24,200.00 -20.9%N/A0.7 $2.00 8/15/202315,300 shares $31,365.00 +183.3%N/A0.7 $2.05 7/31/20235,400 shares $11,070.00 -3.6%N/A0.2 $2.05 7/15/20235,600 shares $11,200.00 +180.0%N/A0.2 $2.00 6/30/20232,000 shares $4,180.00 -16.7%N/A0.1 $2.09 6/15/20232,400 shares $4,848.00 +84.6%N/A0.1 $2.02 5/31/20231,300 shares $2,925.00 -79.4%N/A0.1 $2.25 5/15/20236,300 shares $8,064.00 No ChangeN/A0.4 $1.28 NAMSW Short Interest - Frequently Asked Questions What is NewAmsterdam Pharma's current short interest? Short interest is the volume of NewAmsterdam Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 5,000 shares of NAMSW short. Learn More on NewAmsterdam Pharma's current short interest. What is a good short interest ratio for NewAmsterdam Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NAMSW shares currently have a short interest ratio of 1.0. Learn More on NewAmsterdam Pharma's short interest ratio. Is NewAmsterdam Pharma's short interest increasing or decreasing? NewAmsterdam Pharma saw a decrease in short interest in the month of October. As of October 31st, there was short interest totaling 5,000 shares, a decrease of 16.7% from the previous total of 6,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short NewAmsterdam Pharma stock? Short selling NAMSW is an investing strategy that aims to generate trading profit from NewAmsterdam Pharma as its price is falling. NAMSW shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NewAmsterdam Pharma? A short squeeze for NewAmsterdam Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NAMSW, which in turn drives the price of the stock up even further. How often is NewAmsterdam Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAMSW, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Squeeze DRTSW Short Squeeze WENAW Short Squeeze APLMW Short Squeeze BCTXW Short Squeeze CDIOW Short Squeeze CELUW Short Squeeze CEROW Short Squeeze CLNNW Short Squeeze CDTTW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NAMSW) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.